Granulocyte-Colony Stimulating Factor Market Report

Global and Region Granulocyte-Colony Stimulating Factor Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：197
  • REPORT CODE：GMM976679
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Granulocyte-colony stimulating factor (G-CSF or GCSF), also known as colony-stimulating factor 3 (CSF 3), is a glycoprotein that stimulates the bone marrow to produce granulocytes and stem cellsand release them into the bloodstream. Functionally, it is a cytokine and hormone, a type of colony-stimulating factor, and is produced by a number of different tissues. The pharmaceutical analogs of naturally occurring G-CSF are called filgrastim and lenograstim.G-CSF also stimulates the survival, proliferation, differentiation, and function of neutrophil precursors and mature neutrophils.

    The report details the trend, potential and market size of Granulocyte-Colony Stimulating Factor market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Granulocyte-Colony Stimulating Factormarket, defines the market attractiveness level of Granulocyte-Colony Stimulating Factor market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Granulocyte-Colony Stimulating Factor industry, describes the types of Granulocyte-Colony Stimulating Factor market, the applications of major players and the market size, and deeply analyzes the current situation of the global Granulocyte-Colony Stimulating Factor market and the development prospects and opportunities of Granulocyte-Colony Stimulating Factor industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Granulocyte-Colony Stimulating Factor market in Chapter 13.

    By Player:

    • BioCad

    • Stada Arzneimittel

    • Novartis AG

    • Teva Pharmaceutical Industries

    • Dong-A Socio Group

    • Intas Pharmaceuticals

    • Dr Reddy's Laboratories

    • Amgen

    • Pfizer

    By Type:

    • Capsules

    • Tablets

    • Others

    By End-User:

    • Oncological Diseases

    • Blood Disorders

    • Growth Hormone Deficiencies

    • Chronic and Autoimmune Disorders

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Granulocyte-Colony Stimulating Factor Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Granulocyte-Colony Stimulating Factor Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Granulocyte-Colony Stimulating Factor Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Granulocyte-Colony Stimulating Factor Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Granulocyte-Colony Stimulating Factor Market Analysis and Outlook to 2022

    • 7.1 Global Granulocyte-Colony Stimulating Factor Consumption (2017-2022)

    • 7.2 United States Granulocyte-Colony Stimulating Factor Consumption (2017-2022)

    • 7.3 Europe Granulocyte-Colony Stimulating Factor Consumption (2017-2022)

    • 7.4 China Granulocyte-Colony Stimulating Factor Consumption (2017-2022)

    • 7.5 Japan Granulocyte-Colony Stimulating Factor Consumption (2017-2022)

    • 7.6 India Granulocyte-Colony Stimulating Factor Consumption (2017-2022)

    • 7.7 South Korea Granulocyte-Colony Stimulating Factor Consumption (2017-2022)

    8 Region and Country-wise Granulocyte-Colony Stimulating Factor Market Analysis and Outlook to 2028

    • 8.1 Global Granulocyte-Colony Stimulating Factor Consumption Forecast (2022-2028)

    • 8.2 United States Granulocyte-Colony Stimulating Factor Consumption Forecast (2022-2028)

    • 8.3 Europe Granulocyte-Colony Stimulating Factor Consumption Forecast (2022-2028)

    • 8.4 China Granulocyte-Colony Stimulating Factor Consumption Forecast (2022-2028)

    • 8.5 Japan Granulocyte-Colony Stimulating Factor Consumption Forecast (2022-2028)

    • 8.6 India Granulocyte-Colony Stimulating Factor Consumption Forecast (2022-2028)

    • 8.7 South Korea Granulocyte-Colony Stimulating Factor Consumption Forecast (2022-2028)

    9 Global Granulocyte-Colony Stimulating Factor Market Outlook by Types and Applications to 2022

    • 9.1 Global Granulocyte-Colony Stimulating Factor Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Capsules Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Tablets Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Granulocyte-Colony Stimulating Factor Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Oncological Diseases Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Blood Disorders Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Growth Hormone Deficiencies Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Chronic and Autoimmune Disorders Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Granulocyte-Colony Stimulating Factor Market Outlook by Types and Applications to 2028

    • 10.1 Global Granulocyte-Colony Stimulating Factor Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Capsules Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Tablets Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Granulocyte-Colony Stimulating Factor Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Oncological Diseases Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Blood Disorders Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Growth Hormone Deficiencies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Chronic and Autoimmune Disorders Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Granulocyte-Colony Stimulating Factor Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Granulocyte-Colony Stimulating Factor Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Granulocyte-Colony Stimulating Factor Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Granulocyte-Colony Stimulating Factor Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Granulocyte-Colony Stimulating Factor Market Competitive Analysis

    • 14.1 BioCad

      • 14.1.1 BioCad Company Details

      • 14.1.2 BioCad Granulocyte-Colony Stimulating Factor Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 BioCad Granulocyte-Colony Stimulating Factor Product and Service

    • 14.2 Stada Arzneimittel

      • 14.2.1 Stada Arzneimittel Company Details

      • 14.2.2 Stada Arzneimittel Granulocyte-Colony Stimulating Factor Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Stada Arzneimittel Granulocyte-Colony Stimulating Factor Product and Service

    • 14.3 Novartis AG

      • 14.3.1 Novartis AG Company Details

      • 14.3.2 Novartis AG Granulocyte-Colony Stimulating Factor Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Novartis AG Granulocyte-Colony Stimulating Factor Product and Service

    • 14.4 Teva Pharmaceutical Industries

      • 14.4.1 Teva Pharmaceutical Industries Company Details

      • 14.4.2 Teva Pharmaceutical Industries Granulocyte-Colony Stimulating Factor Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Teva Pharmaceutical Industries Granulocyte-Colony Stimulating Factor Product and Service

    • 14.5 Dong-A Socio Group

      • 14.5.1 Dong-A Socio Group Company Details

      • 14.5.2 Dong-A Socio Group Granulocyte-Colony Stimulating Factor Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Dong-A Socio Group Granulocyte-Colony Stimulating Factor Product and Service

    • 14.6 Intas Pharmaceuticals

      • 14.6.1 Intas Pharmaceuticals Company Details

      • 14.6.2 Intas Pharmaceuticals Granulocyte-Colony Stimulating Factor Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Intas Pharmaceuticals Granulocyte-Colony Stimulating Factor Product and Service

    • 14.7 Dr Reddy's Laboratories

      • 14.7.1 Dr Reddy's Laboratories Company Details

      • 14.7.2 Dr Reddy's Laboratories Granulocyte-Colony Stimulating Factor Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Dr Reddy's Laboratories Granulocyte-Colony Stimulating Factor Product and Service

    • 14.8 Amgen

      • 14.8.1 Amgen Company Details

      • 14.8.2 Amgen Granulocyte-Colony Stimulating Factor Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Amgen Granulocyte-Colony Stimulating Factor Product and Service

    • 14.9 Pfizer

      • 14.9.1 Pfizer Company Details

      • 14.9.2 Pfizer Granulocyte-Colony Stimulating Factor Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Pfizer Granulocyte-Colony Stimulating Factor Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Granulocyte-Colony Stimulating Factor

    • Figure Granulocyte-Colony Stimulating Factor Picture

    • Table Global Granulocyte-Colony Stimulating Factor Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Granulocyte-Colony Stimulating Factor Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Granulocyte-Colony Stimulating Factor Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Granulocyte-Colony Stimulating Factor Consumption by Country (2017-2022)

    • Figure United States Granulocyte-Colony Stimulating Factor Consumption and Growth Rate (2017-2022)

    • Table Europe Granulocyte-Colony Stimulating Factor Consumption and Growth Rate (2017-2022)

    • Figure China Granulocyte-Colony Stimulating Factor Consumption and Growth Rate (2017-2022)

    • Figure Japan Granulocyte-Colony Stimulating Factor Consumption and Growth Rate (2017-2022)

    • Figure India Granulocyte-Colony Stimulating Factor Consumption and Growth Rate (2017-2022)

    • Figure South Korea Granulocyte-Colony Stimulating Factor Consumption and Growth Rate (2017-2022)

    • Figure Global Granulocyte-Colony Stimulating Factor Consumption Forecast by Country (2022-2028)

    • Figure United States Granulocyte-Colony Stimulating Factor Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Granulocyte-Colony Stimulating Factor Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Granulocyte-Colony Stimulating Factor Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Granulocyte-Colony Stimulating Factor Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Granulocyte-Colony Stimulating Factor Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Granulocyte-Colony Stimulating Factor Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Capsules Consumption and Growth Rate (2017-2022)

    • Figure Global Tablets Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Oncological Diseases Consumption and Growth Rate (2017-2022)

    • Figure Global Blood Disorders Consumption and Growth Rate (2017-2022)

    • Figure Global Growth Hormone Deficiencies Consumption and Growth Rate (2017-2022)

    • Figure Global Chronic and Autoimmune Disorders Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Capsules Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Tablets Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oncological Diseases Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Blood Disorders Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Growth Hormone Deficiencies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Chronic and Autoimmune Disorders Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Granulocyte-Colony Stimulating Factor Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Granulocyte-Colony Stimulating Factor Export by Region (Top 5 Countries) (2017-2028)

    • Table BioCad (Foundation Year, Company Profile and etc.)

    • Table BioCad Granulocyte-Colony Stimulating Factor Sales, Price, Value and Gross Profit (2017-2022)

    • Table BioCad Granulocyte-Colony Stimulating Factor Product and Service

    • Table Stada Arzneimittel (Foundation Year, Company Profile and etc.)

    • Table Stada Arzneimittel Granulocyte-Colony Stimulating Factor Sales, Price, Value and Gross Profit (2017-2022)

    • Table Stada Arzneimittel Granulocyte-Colony Stimulating Factor Product and Service

    • Table Novartis AG (Foundation Year, Company Profile and etc.)

    • Table Novartis AG Granulocyte-Colony Stimulating Factor Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis AG Granulocyte-Colony Stimulating Factor Product and Service

    • Table Teva Pharmaceutical Industries (Foundation Year, Company Profile and etc.)

    • Table Teva Pharmaceutical Industries Granulocyte-Colony Stimulating Factor Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Pharmaceutical Industries Granulocyte-Colony Stimulating Factor Product and Service

    • Table Dong-A Socio Group (Foundation Year, Company Profile and etc.)

    • Table Dong-A Socio Group Granulocyte-Colony Stimulating Factor Sales, Price, Value and Gross Profit (2017-2022)

    • Table Dong-A Socio Group Granulocyte-Colony Stimulating Factor Product and Service

    • Table Intas Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Intas Pharmaceuticals Granulocyte-Colony Stimulating Factor Sales, Price, Value and Gross Profit (2017-2022)

    • Table Intas Pharmaceuticals Granulocyte-Colony Stimulating Factor Product and Service

    • Table Dr Reddy's Laboratories (Foundation Year, Company Profile and etc.)

    • Table Dr Reddy's Laboratories Granulocyte-Colony Stimulating Factor Sales, Price, Value and Gross Profit (2017-2022)

    • Table Dr Reddy's Laboratories Granulocyte-Colony Stimulating Factor Product and Service

    • Table Amgen (Foundation Year, Company Profile and etc.)

    • Table Amgen Granulocyte-Colony Stimulating Factor Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen Granulocyte-Colony Stimulating Factor Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Granulocyte-Colony Stimulating Factor Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Granulocyte-Colony Stimulating Factor Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US